A Study of EGFR Monoclonal Antibody (Cetuximab/Nimotuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With EGFR-amplification Advanced Gastric Cancer
Latest Information Update: 06 Dec 2022
At a glance
- Drugs Cetuximab (Primary) ; Nimotuzumab (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Gimeracil/oteracil/tegafur; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 30 Oct 2019 New trial record